CanFite Expands Licensing Agreement to Include Pancreatic Cancer Indication
On January 30, 2024, Can-Fite BioPharma Ltd. announced the expansion of its out-licensing agreement with Ewopharma AG, encompassing the inclusion ...
On January 30, 2024, Can-Fite BioPharma Ltd. announced the expansion of its out-licensing agreement with Ewopharma AG, encompassing the inclusion ...
StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.